Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Resilience19on Feb 28, 2021 1:05pm
182 Views
Post# 32681657

RE:Correct me if I'm wrong

RE:Correct me if I'm wrong@dude, yes but it's probably best to work on a much more conservative scenario of an already ambitious $100M/year earnings. Be it only to be extra cautious.

Whatever else comes on top of that will simply be gravy over an already hefty target 5 times that of 2020!

This said, whatever scenario used, be it the most conservative (say, $40M/ for 2021) or insane (say, $200M for 2021) we are sure to be at $1+ on relatively short order (i.e. around end-May), which should, in due course, put a smile on just about anyone holding DM shares.


Dudeforever wrote: The numbers, should we get this up to 50,000 tests per week, are:

50,000 x 175 = $8,750,000 per week

$8,750,000 x 13.1429 weeks (July, August, September) =  $115,000,375

If we do indeed reach these lofty targets we will be closer to $7 per share.  Doing over $100million in a quarter of high-margin revenue is big boy territory.


<< Previous
Bullboard Posts
Next >>